trending Market Intelligence /marketintelligence/en/news-insights/trending/bwjhnyclsvumvry2gbkcxg2 content esgSubNav
In This List

Osiris Therapeutics CFO resigns; interim replacement named

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Osiris Therapeutics CFO resigns; interim replacement named

Osiris Therapeutics Inc. said Linda Chang resigned as the company's CFO.

The Columbia, Md.-based maker of regenerative medicine named Joel Rogers interim CFO.

Rogers has been Osiris Therapeutics' corporate controller since October 2017, and was previously corporate controller at industrial equipment maker ARC Group Worldwide, Inc.